Los puntos clave no están disponibles para este artículo en este momento.
In this nationally representative survey sample of adults in the US, the prevalence rates of gout and hyperuricemia remained substantial, albeit unchanged, between 2007 and 2016. Despite these rates, only one-third of gout patients were receiving ULT.
Chen-Xu et al. (Tue,) studied this question.